SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Mesoblast Ltd ADR (MESO)

MESO RSS Feed
Add MESO Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 9/26/2016 9:32:09 PM - Followers: 5 - Board type: Free - Posts Today: 0

 

Mesoblast Limited ADR (NASDAQ: MESO)

 


NASDAQ-GS 
 

http://www.mesoblast.com


Non-U.S. Exchange Listing:  (MSB) ASX - Australian Securities Exchange

Quote with Bid and Offer (during ASX market hours)


Qualified Exchange

Mesoblast is listed on several world exchanges:

Symbol Company Name Prime Exchange
MSB.AX Mesoblast Limited Australia Stock Exchange
MESO.MU Mesoblast Limited Munich Stock Exchange
MESO.DE Mesoblast Limited Xetra
MESO.BE Mesoblast Limited Berlin Stock Exchange
MSBta.AX Mesoblast Limited Australia Stock Exchange
MESO.F Mesoblast Limited Frankfurt Stock Exchange

  

 

Company Information:

United States Operations

Australia Corporate Headquarters

Singapore

Mesoblast Inc.

505 Fifth Avenue
Level 3
New York, NY 10017

Mesoblast Limited

55 Collins Street
Level 38
Melbourne 3000

Mesoblast

20 Biopolis Way
#05-01 Centros
Biopreneur
Singapore 138668

TFN: 1 844 889 MESO
TFN: 1 844 889 6376
T: +1 212 880 2060
F: +1 212 880 2061
E: info@mesoblast.com

TFN: 1 800 89 MESO
TFN: 1 800 89 6376
T: +61 3 9639 6036
F: +61 3 9639 6030
E: info@mesoblast.com

TFN: 1 844 889 MESO
TFN: 1 800 889 6376
T: +65 6570 0635
F: +65 6570 0176
E: info@mesoblast.com

Mesoblast -  is a world leader in developing innovative cellular medicines.

We have established what we believe is the industry’s most clinically advanced and diverse portfolio of cell-based products with five programs, two of which are partnered, in active Phase 3 clinical studies or Phase 3-ready, and four programs in Phase 2.

All our clinical programs target significant, under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions.

 

Management: http://www.mesoblast.com/company/management-team

 


Product Candidates Overview: http://www.mesoblast.com/product-candidates/product-candidates-overview
 

Investors & Media Home: http://investorsmedia.mesoblast.com/phoenix.zhtml?c=187006&p=irol-irhome

 

SEC Filings: http://www.sec.gov/cgi-bin/browse-edgar?company=mesoblast&owner=exclude&action=getcompany

 

Investor & Media Contact:

Michael Schuster
Global Head, Investor Relations

T: + 1 212 880 2060
E: michael.schuster@mesoblast.com

Julie Meldrum
Global Head, Corporate Communications

T: + 61 3 9639 6036
E: julie.meldrum@mesoblast.com

 

 

 

Non-U.S. Exchange Listing

(MSB) ASX - Australian Securities Exchange
Qualified Exchange

 

NASDAQ-GS   

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MESO
Current Price
Volume:
Bid Ask Day's Range
SureTrader
MESO News: MD Anderson Cancer Center and National Institutes of Health to Fund Clinical Trial Combining Two Proprietary Mesoblast Techno... 12/06/2016 06:00:00 AM
MESO News: Report of Foreign Issuer (6-k) 11/15/2016 06:23:10 AM
MESO News: Report of Foreign Issuer (6-k) 11/14/2016 05:39:34 PM
MESO News: Mesoblast Provides Corporate Update and Financial Results for the First Quarter Ended September 30, 2016 11/14/2016 04:52:33 PM
MESO News: Mesoblast Announces Successful Interim Futility Analysis In Phase 3 Trial For Acute Graft Versus Host Disease 11/14/2016 06:00:00 AM
PostSubject
#139   What is this worth? Noticed some drugs in P3 Stoxx1 09/26/16 09:32:09 PM
#138   Sending ticker via pm. KarinCA 02/04/14 04:43:03 PM
#137   Thanks. Who is their competitor? Stockbuilder 02/04/14 04:27:29 PM
#136   Without replying to a post there's no one KarinCA 02/04/14 03:39:53 PM
#135   POSITIVE SPINAL DISC REPAIR TRIAL RESULTS USING MESOBLAST SuperSquirrel 01/30/14 12:10:59 AM
#134   SuperSquirrel 01/30/14 12:10:40 AM
#133   Mesoblast Is No Match For Pluristem's IP And Manufacturing SuperSquirrel 01/28/14 09:31:50 PM
#132   Mesoblast Reports Positive Type 2 Diabetes Trial Results SuperSquirrel 12/03/13 11:30:15 PM
#131   New Japanese Regenerative Medicine Legislation and Commercial Opportunities SuperSquirrel 11/25/13 12:39:09 PM
#130   Mesoblast's Cell Therapy Strengthens Native Heart Function In SuperSquirrel 11/18/13 09:58:44 PM
#129   Continue to wait for an answer. Stockbuilder 10/24/13 08:34:47 AM
#128   Just discovered this interesting stock? Why is no Stockbuilder 09/19/13 09:42:25 AM
#127   $MBLTY - Mesoblast's Strong Cash Position Enables Execution KarinCA 09/04/13 01:25:45 AM
#126   Mesoblast Receives $4.3 Million from Australian Government for SuperSquirrel 07/18/13 07:53:12 PM
#125   MESOBLAST'S PRECLINICAL TRIAL RESULTS OF INTRACORONARY CELL THERAPY SuperSquirrel 05/14/13 11:28:03 PM
#124   The Vatican's Pontifical Council for Culture, NeoStem, The SuperSquirrel 04/11/13 12:34:25 AM
#123   The Stem Cell Revolution Can Jump Start Your SuperSquirrel 03/17/13 12:12:03 PM
#122   Mesoblast Completes A$170m Private Placement SuperSquirrel 03/17/13 12:10:46 PM
#121   MBLTY - FDA Agreement on Mesoblast's Use of KarinCA 02/13/13 01:17:38 PM
#120   It will be interesting to see how long KarinCA 12/05/11 02:26:17 AM
#119   It's quite interesting to see how this has KarinCA 10/08/11 01:10:48 PM
#118   MBLTY - Mesoblast Receives Clearance to Begin First KarinCA 09/05/11 09:16:37 PM
#117   Mesoblast Receives FDA Clearance for Phase 3 Bone KarinCA 07/07/11 11:51:39 AM
#116   KEY PATENTS GRANTED IN UNITED STATES STRENGTHEN KarinCA 06/02/11 01:33:18 PM
#115   Mesoblast deal inspires Teva to swoop on Cephalon SuperSquirrel 05/08/11 11:27:54 PM
#114   Teva: $500 Million Cost Savings From Cephalon Buy SuperSquirrel 05/04/11 09:06:34 PM
#113   Mesoblast Limited (ASX:MSB) Included In Standard And Poor/ASX SuperSquirrel 04/18/11 06:25:22 AM
#112   Mesoblast Limited (ASX:MSB) (PINK:MBLTY) wishes to inform the SuperSquirrel 04/08/11 03:46:34 PM
#111   I'll have to agree with you there... lol KarinCA 04/07/11 05:45:38 PM
#110   The CEPH deal with Mesoblast did not seem SuperSquirrel 03/29/11 10:28:42 PM
#109   I agree and another 52 week high today. SuperSquirrel 03/29/11 05:06:32 PM
#108   MBLTY is one of the best in the KarinCA 03/07/11 12:33:13 PM
#107   Have you looked at it lately? KarinCA 03/06/11 09:19:36 PM
#106   Mesoblast's results are out of this world. CEPH SuperSquirrel 03/04/11 04:26:24 PM
#105   Interview: Mesoblast's Cephalon deal was late CEO's vision SuperSquirrel 03/03/11 06:41:18 PM
#104   Mesoblast Limited Issues Shares To Cephalon International Holdings SuperSquirrel 02/11/11 11:16:47 PM
#103   Mesoblast Reports Strong Cash Position SuperSquirrel 02/01/11 06:45:23 AM
#102   ohhhhhhhhhhhhhhhhhhhhhh yeahhhhhhhhhhhhhh biomanbaba 01/30/11 10:34:20 PM
#101   MBLTY has been pretty good. ;) KarinCA 01/13/11 03:01:08 PM
#100   52 week highs are just too common to SuperSquirrel 01/13/11 02:38:56 PM
#99   It's a great company. I'm amazed at KarinCA 01/12/11 11:14:00 AM
#98   I found Mesoblast a few weeks ago when biocqr 01/12/11 11:02:12 AM
#97   Interim Results From Mesoblast's Phase 2 Heart Failure biocqr 01/12/11 10:43:08 AM
#96   Cephalon, Inc. Announces Positive Interim Results From Mesoblast SuperSquirrel 01/10/11 06:48:29 PM
#95   Pluristem’s Potential Value Highlighted by Cephalon-Mesoblast Deal SuperSquirrel 01/10/11 06:47:29 PM
#94   MEOBF pink or MBLTY otc ADR KarinCA 12/09/10 01:45:54 PM
#93   The ibox is updated to show pink sheet current. KarinCA 12/08/10 03:58:51 AM
#92   Cephalon Buys Rights to Mesoblast Adult Stem Cell Therapies KarinCA 12/08/10 03:42:34 AM
#91   Mesoblast Limited (ASX:MSB) Clear To Proceed With Angioblast Acquisition SuperSquirrel 11/19/10 05:46:28 PM
#90   Melbourne, Nov 16, 2010 (ABN Newswire) - Regenerative SuperSquirrel 11/16/10 03:53:39 PM
PostSubject